SCHEMBL21264868

SCHEMBL21264868

C=N/C(=N\C=C(/C)OCC1CCNCC1)c1cccc(Cn2cc(B3OC(C)(C)C(C)(C)O3)cc(F)c2=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21322268 0.75 MET (0.41) —
SCHEMBL19806007 0.63 DBH (0.43) —
SCHEMBL19806130 0.63 MAPK10 (0.45) —
SCHEMBL23714114 0.62 MET (0.56) —
SCHEMBL19806033 0.59 IDO1 (0.33) —
SCHEMBL21322269 0.58 MET (0.44) —
SCHEMBL15836994 0.57 BRD4 (0.40) —
SCHEMBL18764611 0.56 ALDH1A1 (0.47) —
SCHEMBL16622998 0.55 TDP1 (0.57) —
SCHEMBL31222865 0.55 LPL (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501443-B2 Pyridone compound as c-met inhibitor FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) 2019-12-10 — — US disclosed
US-20190248763-A1 PYRIDONE COMPOUND AS C-MET INHIBITOR FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) 2019-08-15 — — US disclosed
Send feedback